These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 36945926)

  • 1. Cognitive outcomes of transcranial magnetic stimulation in treatment-resistant depression: a randomized controlled study.
    Yıldız T; Oğuzhanoğlu NK; Topak OZ
    Turk J Med Sci; 2023 Feb; 53(1):253-263. PubMed ID: 36945926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
    Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
    Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive outcomes of TMS treatment in bipolar depression: Safety data from a randomized controlled trial.
    Myczkowski ML; Fernandes A; Moreno M; Valiengo L; Lafer B; Moreno RA; Padberg F; Gattaz W; Brunoni AR
    J Affect Disord; 2018 Aug; 235():20-26. PubMed ID: 29631203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial.
    Huang ML; Luo BY; Hu JB; Wang SS; Zhou WH; Wei N; Hu SH; Xu Y
    Aust N Z J Psychiatry; 2012 Mar; 46(3):257-64. PubMed ID: 22391283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation With a 2-Coil Device in Treatment-Resistant Major Depressive Disorder.
    Kavanaugh BC; Aaronson ST; Clarke GN; Holtzheimer PE; Johnson CW; McDonald WM; Schneider MB; Carpenter LL
    J ECT; 2018 Dec; 34(4):258-265. PubMed ID: 29613944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repetitive transcranial magnetic stimulation in patients with drug-resistant major depression: A six-month clinical follow-up study.
    Concerto C; Lanza G; Cantone M; Ferri R; Pennisi G; Bella R; Aguglia E
    Int J Psychiatry Clin Pract; 2015; 19(4):252-8. PubMed ID: 26398527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of transcranial magnetic stimulation in treatment-resistant depression.
    Akpınar K; Oğuzhanoğlu NK; Uğurlu TT
    Turk J Med Sci; 2022 Aug; 52(4):1344-1354. PubMed ID: 36326400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
    Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
    Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.
    O'Reardon JP; Solvason HB; Janicak PG; Sampson S; Isenberg KE; Nahas Z; McDonald WM; Avery D; Fitzgerald PB; Loo C; Demitrack MA; George MS; Sackeim HA
    Biol Psychiatry; 2007 Dec; 62(11):1208-16. PubMed ID: 17573044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial.
    Fitzgerald PB; Brown TL; Marston NA; Daskalakis ZJ; De Castella A; Kulkarni J
    Arch Gen Psychiatry; 2003 Oct; 60(10):1002-8. PubMed ID: 14557145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Deep Transcranial Magnetic Stimulation in Office Workers with Treatment-Resistant Depression: A Randomized, Double-Blind, Sham-Controlled Trial.
    Matsuda Y; Kito S; Igarashi Y; Shigeta M
    Neuropsychobiology; 2020; 79(3):208-213. PubMed ID: 31955155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Efficacy and Safety of Transcranial Magnetic Stimulation in Treatment-Resistant Bipolar Depression.
    Zengin G; Topak OZ; Atesci O; Culha Atesci F
    Psychiatr Danub; 2022; 34(2):236-244. PubMed ID: 35772133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in quality of life with left prefrontal transcranial magnetic stimulation in patients with pharmacoresistant major depression: acute and six month outcomes.
    Solvason HB; Husain M; Fitzgerald PB; Rosenquist P; McCall WV; Kimball J; Gilmer W; Demitrack MA; Lisanby SH
    Brain Stimul; 2014; 7(2):219-25. PubMed ID: 24332384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: a double-blind, randomized, sham-controlled trial.
    Croarkin PE; Elmaadawi AZ; Aaronson ST; Schrodt GR; Holbert RC; Verdoliva S; Heart KL; Demitrack MA; Strawn JR
    Neuropsychopharmacology; 2021 Jan; 46(2):462-469. PubMed ID: 32919400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two Versus One High-Frequency Repetitive Transcranial Magnetic Stimulation Session per Day for Treatment-Resistant Depression: A Randomized Sham-Controlled Trial.
    Theleritis C; Sakkas P; Paparrigopoulos T; Vitoratou S; Tzavara C; Bonaccorso S; Politis A; Soldatos CR; Psarros C
    J ECT; 2017 Sep; 33(3):190-197. PubMed ID: 28072660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, Safety and Tolerability of Augmentative rTMS in Treatment of Major Depressive Disorder (MDD): A Prospective Cohort Study in Croatia.
    Filipcic I; Milovac Z; Sucic S; Gajsak T; Filipcic IS; Ivezic E; Aljinovic V; Orgulan I; Penic SZ; Bajic Z
    Psychiatr Danub; 2017 Mar; 29(1):31-38. PubMed ID: 28291972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial.
    Avery DH; Isenberg KE; Sampson SM; Janicak PG; Lisanby SH; Maixner DF; Loo C; Thase ME; Demitrack MA; George MS
    J Clin Psychiatry; 2008 Mar; 69(3):441-51. PubMed ID: 18294022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive safety of dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression.
    Schulze L; Wheeler S; McAndrews MP; Solomon CJ; Giacobbe P; Downar J
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1213-26. PubMed ID: 27157074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression.
    Avery DH; Holtzheimer PE; Fawaz W; Russo J; Neumaier J; Dunner DL; Haynor DR; Claypoole KH; Wajdik C; Roy-Byrne P
    Biol Psychiatry; 2006 Jan; 59(2):187-94. PubMed ID: 16139808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.